The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer

被引:3
作者
Khatami, Fatemeh [1 ]
Aghamir, Zahra Sadat [2 ]
Jahanshahi, Fatemeh [3 ]
Feiz-Abadi, Seyed Ariana [1 ]
Birang, Fatemeh [4 ]
Khoshchehreh, Mahdi [5 ]
Shabestari, Alireza Namazi [6 ]
Aghamir, Seyed Mohammad Kazem [1 ]
机构
[1] Univ Tehran Med Sci, Urol Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Fac Dent, Tehran, Iran
[3] Iran Univ Med Sci, Tehran, Iran
[4] Univ Tehran Med Sci, Allied Med Fac, Dept Med Lab Sci, Tehran, Iran
[5] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA
[6] Univ Tehran Med Sci, Sch Med, Dept Geriatr Med, Tehran, Iran
关键词
Chimeric Antigen Receptor T cell; Engineered T cell receptor; Natural Killer cell; Tumor-Infiltrating Lymphocyte; T-CELLS; THERAPY; CHEMOTHERAPY; LYMPHOMA; FUTURE; NK;
D O I
10.30498/ijb.2022.294933.3094
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Context: The immune system is directly linked to the tumors, from tumor formation to the tumor's development and metastasis. So, the interest of scientists over the protective immunological mechanisms has increased and shown gifted strategy in cancer treatment. Evidence acquisition: Genetic engineering and cellular immunotherapy are two different advanced molecular mechanisms to modify the immune responses and genome. Gene manipulation is the bioengineering technology that allows vectors to transfer new genetic information into the target cells. Cellular immunotherapy is an excellent strategy that connects the body's immune system to fight cancer. Results & Conclusions: This review described that combination of genetic engineering and cellular immunotherapy has brought the novel antitumor repressive molecules stopping the tumor tissue immune tolerance and significantly expanding cancer therapy's effectiveness. Usually, cell immunotherapy and genetic engineering are considered two independent processes, and, in this review, we believe them in combinations. Here, we review these two novel approaches, and they are both combinations in terms of technological advances and clinical experience.
引用
收藏
页数:14
相关论文
共 57 条
[1]  
Aghamir S.M.K., 2021, Transl. Res. Urol., V3, P10
[2]   Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors [J].
Aghamir, Seyed Mohammad Kazem ;
Heshmat, Ramin ;
Ebrahimi, Mehdi ;
Khatami, Fatemeh .
EPIGENETICS INSIGHTS, 2020, 13
[3]   The Impact Of Succinate Dehydrogenase Gene (SDH) Mutations In Renal Cell Carcinoma (RCC): A Systematic Review [J].
Aghamir, Seyed Mohammad Kazem ;
Heshmat, Ramin ;
Ebrahimi, Mehdi ;
Ketabchi, Seyed Ebrahim ;
Dizaji, Somayeh Parichehreh ;
Khatami, Fatemeh .
ONCOTARGETS AND THERAPY, 2019, 12 :7929-7940
[4]  
Aghamir SMK., 2019, Translational Research in Urology, V1, P27, DOI DOI 10.22034/AU.2020.226654.1012
[5]  
Aghamir ZS, 2020, TRANSL RES UROLOGY, V3, P96, DOI [10.22034/TRU.2021.269615.1060, DOI 10.22034/TRU.2021.269615.1060]
[6]  
[Anonymous], 2021, FDA approves pembrolizumab combination for the first-line treatment of cervical cancer
[7]   CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer [J].
Azangou-Khyavy, Mohammadreza ;
Ghasemi, Mobina ;
Khanali, Javad ;
Boroomand-Saboor, Melika ;
Jamalkhah, Monire ;
Soleimani, Masoud ;
Kiani, Jafar .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[8]   NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs [J].
Beziat, Vivien ;
Liu, Lisa L. ;
Malmberg, Jenny-Ann ;
Ivarsson, Martin A. ;
Sohlberg, Ebba ;
Bjorklund, Andreas T. ;
Retiere, Christelle ;
Sverremark-Ekstrom, Eva ;
Traherne, James ;
Ljungman, Per ;
Schaffer, Marie ;
Price, David A. ;
Trowsdale, John ;
Michaelsson, Jakob ;
Ljunggren, Hans-Gustaf ;
Malmberg, Karl-Johan .
BLOOD, 2013, 121 (14) :2678-2688
[9]   New approaches to genetic therapies for cystic fibrosis [J].
Boyd, A. Christopher ;
Guo, Shuling ;
Huang, Lulu ;
Kerem, Batsheva ;
Oren, Yifat S. ;
Walker, Amy J. ;
Hart, Stephen L. .
JOURNAL OF CYSTIC FIBROSIS, 2020, 19 :S54-S59
[10]   CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition [J].
Buchbinder, Elizabeth I. ;
Desai, Anupam .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (01) :98-106